Die Marke ELIVRAL, gegründet in 2014 (Vereinigte Staaten von Amerika), von der 588 Schwestermarken und 17478 konkurrierende Marken. ELIVRAL ist im Besitz von ELI LILLY AND COMPANY, notiert an der Börse von New York . ELIVRAL gehört zum Geschäftsbereich Arzneimittelhersteller.
Kaufen Sie die ELI LILLY AND COMPANY Aktie mit
(0 % Provision und Bruchteile)
Ihr Kapital ist einem Risiko ausgesetzt. Andere Gebühren fallen an. Weitere Informationen finden Sie unter etoro.com/trading/fees.
Andere Marken
ELI LILLY AND COMPANY
-
A
- Avid Radiopharmaceuticals
- Alnara Pharmaceuticals
- Applied Molecular Evolution
- AurKa Pharma
- AUMBIQUE
- AUMBIQ
- ABAYSAGLAR
- AXIRON TWIST & DOSE
- ABASAGLAR
- ACCOMPLISH
- APLEVOW
- APLEVOS
- APLEVO CERTUIT
- APLEVO CRUISIT
- APLEVO FLASHTEC
- APLEVO INTELIVA
- APLEVO JILITY
- APLEVO SWIFTEC
- APLEVO SWIFTUIT
- APLEVO TRUITION
- APLEVO VERSTIA
- AFIGILE
- ABAZRIA
- AMYVID
- APPELLUS
- ANELYNE
- ALIBRET
- APLEEVO
- ANNCYZ
- ANNCYZE
- APLEVEO
- ARRYZING
- ARYZING
- ABASRIA
- AXXERON
- ATONZIA
- AMODIF
- AXIRON
- ADCIRCA
- AMYLYTE
- AMYSCAN
- AMYPET
- AMYVUE
- AXERON
- ARMAMENT
- ANDEPTRA
- ADVACADE
- AKODAR
- APLEVANT
- APLEVOL
- APLEAVO
- APLEVO
- ACIRQA
- ADCIRQA
- ARICLAIM
- ARXXANT
- ANSWERS THAT MATTER
- ANDEPRA
- ARXANT
- ARVANT
- ATENTEN
- APTHELA
- ALIMTA
- ARMAVE
- AMZET
- AXID
-
B
-
C
- CoLucid Pharmaceuticals
- CESLADA
- CYRAMZA
- CERTAMARK
- CERTUIT
- CYRAMZE
- CYRAMZO
- CYRRAMZ
- CYRAMGIO
- CYRAMZ
- CIAVOR
- CEZYCE
- CORPOMIN
- CORGLUTRIS
- CORGLUTAN
- CORGLUTAL
- CYRRAMZA
- CYRAMZZA
- CYRAMZZ
- CYRAMSA
- CYLIFRA
- CERYOND
- COPELLOR
- COHEALEN
- CONTINULON
- CIRAMZ
- CIRAMZA
- CHERISTIN
- CONVERGIS
- CHERSTIVA
- CONQUEST
- C20
- C10
- CERENTRA
- CREAZOX
- CYMBALTA
- COYOTE
- CY-OTE
- CYVADE
- CHEF1
- CYMBALTA BECAUSE DEPRESSION HURTS
- COMFORTIS
- CIALIS
-
D
-
E
- ElanCopro
- ELANCO MYVETPROGRAM
- ELCEVEVE
- ENEVYBE
- EVABAVE
- EVABECT
- EFERLEZ
- ELUNATEY
- ESENGLAR
- EMUGLAR
- ELANCO KETO-TRACK
- ELUNATY
- ELYUNATE
- ENDEVRON
- EXPERIOR
- EXPIDANN
- EASYHOLD
- EMMECENT
- EBLINIAL
- EBZYVE
- EMBLACE
- ELIVRIAL
- EMVENIA
- ESUVEL
- EZAMBRISS
- EZAMBBRIS
- EZEMBRIS
- ENGLUCENT
- EGLUCENT
- ELUNATE
- EPARVIV
- EPARVIVE
- EPAREM
- ENTHRYV
- EXPIDAN
- EZAMBRIS
- ENVILLOW
- ETUNITY
- EMBOLZEN
- EZOLVEN
- ESSENCIL
- ENZAVA
- ENCLUSION
- ENKINDA
- EFIENT
- ELMETRA
- ELAMETRA
- ELEMETRA
- EFFEANT
- EFIANTE
- EFFEANTE
- ERBITUX
- EFFIENT
- ENTUZITY
- ERBITUX CETUXIMAB
- ENDOCLONE
- ERBLOC
- EXTINOSAD
- ELANTIL
- ELANTIK
- ELECTOR
- ELANCID
- ELATRIM
- ELANCO ANIMAL HEALTH HTS Health Tracking System
- ELANCO
-
F
-
G
-
H
- Hypnion
- Heart Rhythm Technologies
- HALPRYZA
- HYBREED
- HEALTHY START
- HARMONTA
- HARMONDRA
- HARMONTRI
- HARMONTRU
- HARMONTRY
- HARMONTRO
- HAVEN
- HARMONNTRA
- HARMONTTRA
- HARMONTRA
- HUMAPEN SAVVIO
- HABEREX
- HTSi
- HUMABELA
- HUMAPEN
- HUMAHALE
- HUMALOG BAZAL
- HUMALOG MYPEN
- HUMALOG KWIKPEN
- HUMALOG CONFIPEN
- HEMICELL
- HUMABASE
- HUMALOG SAVVIO
- HUMALOG MIRIO
- HUMALOG INZIO
- HUMAPEN ERGO
- HUMAPEN MEMOIR
- HUMAPEN LUXURA
- HUMATROPEN
- HUMALOG MIX25
- HUMALOG MIX50
- HUMALOG MIX75
- HUMATROPE
-
I
-
J
-
K
-
L
-
M
-
N
-
O
-
P
- PLYNAMIC
- PORTRAZZA
- PIGTRACK
- PERPETIUM
- PLATFORM
- PACE A Lilly Oncology Initiative
- PORTRAZZ
- PORTTRAZA
- PORRTRAZA
- PONTTEVIA
- PONSTEVIA
- PONTREVIA
- PAVENI
- PD2 PHENOTYPIC DRUG DISCOVERY
- PACEVIOR
- PACEVIOS
- PLAQUEVID
- PONTEVIA
- PORTRAZA
- PLINIAD
- PALOMYS
- PANORAMIS
- PALOMYPEN
- PRENU
- PATHGATE
- PERTINENZ
- Peaks & Valleys
- PALOMIS
- PAFASE
- PASPORT
- POZIQ
- POZIQUE
- PEMTAZAR
- PROMTAR
- PROZAC
-
Q
-
R
-
S
- STARTGLAR
- SHINE
- SAVVIOCONNECT
- SCRATCH TRACKER
- STEADYGRIP
- STANCE
- SUROSOLVE
- STAURENZA
- SEQUNE
- SEFFONY
- SPURVIXA
- SILLPURA
- SOLLPURA
- SKYCIS
- SELF EXPRESSIONS OF PAIN
- SEFONY
- STYLAPEN
- SURMAX
- STAURENZAKT
- STAURENZAK
- SAVVIOPEN
- STANDGUARD
- SYLVATA
- SOHO SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES
- STRATTERA
- STELLAMUNE
- SOLPURA
- SGX Pharmaceuticals
-
T
- THE ELANCO PULSE INSTITUTE
- TAUVID
- TANGLEVID
- TWIST & DOSE
- TALTZ
- TRUEHOLD
- TRUEGRIP
- THE SOCIAL VETWORK
- TRENUVIS
- TECULEN
- TARGET D2 TARGET DRUG DISCOVERY
- TRUNEXUS
- TANSTRIVE
- TIRVEO
- TAZLUM
- TOLIENT
- TEAMMATE
- TRAILHEAD
- TRANSGEVITY
- TRIFEXIS
- TRITECTIS
- TURZINE
- Targeted Oncology
- THE LILLY MDR-TB PARTNERSHIP
- TREONFA
- TOPMAX
- TYFOLAR
- TACLERON
- TYLAN
- Togirén
-
U
-
V
-
W
-
X
-
Y
-
Z
- ZELUNATE
- ZORBIUM
- ZECIFFIN
- ZINLISTIQ
- ZANLISTIQ
- ZANLISTIC
- ZYSE
- ZIPSTA
- ZEAVE
- ZENEFOST
- ZENLISTIC
- ZERMAVA
- ZIMPROVA
- ZOXI
- ZYRELPREV
- ZYPRELPREV
- ZYREZVO
- ZYPREZVO
- ZEARL
- ZYPHE
- ZYPREXA
- ZALUTRIA
- ZAFIANT
- ZEFYANT
- ZEFIENT
- ZYADHERA
- ZADHERA
- ZYPADHERA
- ZYPREXARELPREV
- ZYPREXADHERA
- ZYPREXAREZVO
- ZYPREXA ADHERA
- ZELLETRA
- ZALUTIA
- ZYMERYS
- ZEFFIANT
- ZEFIANT
-
4
